Revive Formulations India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.84 Cr
as on 10-12-2024
- Revenue 24.77%
(FY 2023)
- Profit -6.06%
(FY 2023)
- Ebitda 4.20%
(FY 2023)
- Net Worth 34.66%
(FY 2023)
- Total Assets 3.92%
(FY 2023)
About Revive Formulations India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.84 Cr.
Chakravarthy Murugan, Ramakesu Pillai, and Sakthidaran Swamirajan serve as directors at the Company.
- CIN/LLPIN
U36900TN2015PTC099527
- Company No.
099527
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Villupuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Revive Formulations India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sakthidaran Swamirajan  | Additional Director | 28-Jan-2016 | Current |
| Ramakesu Pillai | Additional Director | 09-Apr-2015 | Current |
| Chakravarthy Murugan | Director | 06-Mar-2015 | Current |
Financial Performance of Revive Formulations India.
Revive Formulations India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.77% increase. The company also saw a slight decrease in profitability, with a 6.06% decrease in profit. The company's net worth Soared by an impressive increase of 34.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Revive Formulations India?
Unlock access to Revive Formulations India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Thanvanthri Marketing Private LimitedActive 9 years 20 daysRamakesu Pillai and Sakthidaran Swamirajan are mutual person
Charges (Loans)
₹28.36 M
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 1.89 Cr
- Indian Bank : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Sidbi | ₹1.00 Cr | Open |
| 07 Jun 2021 | Sidbi | ₹8.86 M | Open |
| 06 Jun 2020 | Indian Bank | ₹4.50 M | Open |
| 25 Jan 2017 | Indian Bank | ₹2.00 M | Open |
| 29 Dec 2015 | Indian Bank | ₹3.00 M | Open |
How Many Employees Work at Revive Formulations India?
Revive Formulations India has a workforce of 43 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Revive Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revive Formulations India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
